SkyView Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$699K Buy
19,010
+351
+2% +$16.6K 0.09% 161
2025
Q4
$949K Buy
18,659
+302
+2% +$15.4K 0.12% 128
2025
Q3
$1.02M Buy
18,357
+424
+2% +$24.8K 0.13% 117
2025
Q2
$1.23M Buy
17,933
+353
+2% +$24K 0.18% 86
2025
Q1
$1.22M Buy
+17,580
New +$1.45M 0.18% 85
2024
Q3
Sell
-14,125
Closed -$2.02M 324
2024
Q2
$2.02M Buy
14,125
+49
+0.3% +$6.49K 0.36% 45
2024
Q1
$1.81M Buy
+14,076
New +$1.68M 0.33% 46
2023
Q4
Sell
-12,364
Closed -$1.12M 386
2023
Q3
$1.12M Sell
12,364
-8,298
-40% -$731K 0.46% 54
2023
Q2
$1.67M Buy
20,662
+5,652
+38% +$462K 0.42% 66
2023
Q1
$1.19M Buy
15,010
+266
+2% +$18.9K 0.28% 90
2022
Q4
$998K Sell
14,744
-104
-0.7% -$6.1K 0.3% 105
2022
Q3
$740K Buy
14,848
+1,406
+10% +$75.3K 0.22% 158
2022
Q2
$748K Buy
13,442
+5,518
+70% +$306K 0.2% 168
2022
Q1
$441K Buy
7,924
+164
+2% +$8.42K 0.1% 264
2021
Q4
$435K Hold
7,760
0.1% 247
2021
Q3
$373K Hold
7,760
0.1% 229
2021
Q2
$262K Hold
7,760
0.12% 161
2021
Q1
$262K Hold
7,760
0.12% 169
2020
Q4
$271K Buy
+7,760
New +$268K 0.13% 167

Other funds holding NVO

SkyView Investment Advisors's NVO Position: Q1 2026 in Review

SkyView Investment Advisors increased its Novo Nordisk (NVO) stake by 1.9% in Q1 2026, buying an estimated $16.6K and bringing the position to 19,010 shares worth $699K. The position accounts for 0.09% of the portfolio, ranked #161.

SkyView Investment Advisors first reported a position in NVO in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.02M in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • SkyView Investment Advisors held 19,010 shares of Novo Nordisk worth $699K as of Q1 2026.
  • SkyView Investment Advisors bought 351 Novo Nordisk shares in Q1 2026, an estimated $16.6K.
  • Novo Nordisk made up 0.09% of SkyView Investment Advisors's portfolio in Q1 2026, its #161 holding.
  • SkyView Investment Advisors first reported a position in Novo Nordisk in Q4 2020 and has held it in 19 quarters since.
  • SkyView Investment Advisors's Novo Nordisk position peaked at $2.02M in Q2 2024.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.